Colgate’s Ayurvedic Bet To Protect Turf Starts To Pay Off
Colgate Palmolive India Ltd.'s offensive to protect domination has started paying off for India's largest toothpaste company.
Market share of the maker of namesake brand rose 40 basis points over the previous quarter to 52.7 percent in September, according to a report by SBI Cap Securities. That's the biggest jump in nine quarters and the first gain in five.
That came as the company aggressively pushed its herbal variants—Swarna Vedshakti and Cibaca Vedshakti launched in August 2016—to counter the challenge from Yoga guru Ramdev-backed Patanjali Ayurved Ltd.
Patanjali ate into the share of rivals with its Dant Kanti toothpaste, pulling along the ayurvedic market in the last two years. That even helped herbal products maker Dabur India Ltd. But Colgate Palmolive's share fell from the peak of 58 percent in April-June 2015 to its lowest 52.3 percent in the first quarter of the ongoing financial year.
To be sure, the company's market share jumped at least twice in the past two years, only to resume the slide. This time, Colgate Palmolive is far more aggressive.
The company is not only looking to protect its market in core brands but also gain share in “naturals” category, HDFC Securities said in a report after its July-September numbers. Though launched more than two years ago, it rolled out the herbal variants across India only in the previous quarter.
It also lowered prices of Swarna Vedshakti by 10-12 percent across all pack sizes, a Colgate distributor said on the condition of anonymity.
Swarna Vedshakti continues to drive the company's performance in the natural portfolio, JPMorgan said in a report. “The recent national rollout has received a good response and repeat purchases show positive consumer confidence.”
Colgate Palmolive, according to SBI Cap Securities, also increased spending on advertisement and promotions. And it's trying to increase its reach.
The toothpaste maker's sales teams have begun surveying the market to connect retail stores that don't stock its products with local distributors, the distributor quoted above said, adding that the company added 125,000 retail outlets to its existing network in Maharashtra alone.
BloombergQuint has yet to get a response from Colgate Palmolive to emailed queries.
Intense Competition
Still, it's early to say that the rebound will sustain because competition is only getting intense. That's putting pressure on pricing. The focus in the market has shifted to lower-sized packs, Sunil Duggal, chief executive officer of Dabur India Ltd., told investors in a conference call post the company's September quarter earnings. The Rs 10 pack was earlier a market dominated by Colgate's Cibaca and Dabur's Babul, but Patanjali's Dant Kanti and Colgate's Vedshakti are available at that price for the last two quarters.
“I think disruption actually came from the Ayurvedic players and whether it's Colgate or Patanjali, everybody is investing invasively at Rs 10 price points,” Duggal said. “That has caused some damage.”
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets
-
India Is Going Abroad For Critical Minerals. But It May Take Years To Pay Off | The Reason Why
Although India's steps are in the right direction, they remain modest compared with India's growing dependence.